OrbiMed’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302M | Hold |
|
|||||
|
2025
Q1 | $284M | Sell |
|
|||||
|
2024
Q4 | $282M | Sell |
|
|||||
|
2024
Q3 | $274M | Hold |
|
|||||
|
2024
Q2 | $252M | Hold |
|
|||||
|
2024
Q1 | $224M | Sell |
|
|||||
|
2023
Q4 | $191M | Hold |
|
|||||
|
2023
Q3 | $175M | Sell |
|
|||||
|
2023
Q2 | $183M | Sell |
|
|||||
|
2023
Q1 | $190M | Sell |
|
|||||
|
2022
Q4 | $180M | Hold |
|
|||||
|
2022
Q3 | $151K | Sell |
|
|||||
|
2022
Q2 | $163K | Sell |
|
|||||
|
2022
Q1 | $204M | Sell |
|
|||||
|
2021
Q4 | $236M | Sell |
|
|||||
|
2021
Q3 | $253M | Sell |
|
|||||
|
2021
Q2 | $296M | Hold |
|
|||||
|
2021
Q1 | $267M | Buy |
|
|||||
|
2020
Q4 | $235M | Buy |
|
|||||
|
2020
Q3 | $185M | Hold |
|
|||||
|
2020
Q2 | $170M | Hold |
|
|||||
|
2020
Q1 | $158M | Buy |
|
|||||
|
2019
Q4 | $211M | Sell |
|
|||||
|
2019
Q3 | $214M | Sell |
|
|||||
|
2019
Q2 | $290M | Buy |
|
|||||
|
2019
Q1 | $222M | Hold |
|
|||||
|
2018
Q4 | $205M | Sell |
|
|||||
|
2018
Q3 | $303M | Sell |
|
|||||
|
2018
Q2 | $313M | Sell |
|
|||||
|
2018
Q1 | $284M | Sell |
|
|||||
|
2017
Q4 | $257M | Sell |
|
|||||
|
2017
Q3 | $391M | Sell |
|
|||||
|
2017
Q2 | $399M | Sell |
|
|||||
|
2017
Q1 | $381M | Sell |
|
|||||
|
2016
Q4 | $357M | Sell |
|
|||||
|
2016
Q3 | $410M | Sell |
|
|||||
|
2016
Q2 | $541M | Buy |
|
|||||
|
2016
Q1 | $423M | Sell |
|
|||||
|
2015
Q4 | $451M | Buy |
|
|||||
|
2015
Q3 | $394M | Buy |
|
|||||
|
2015
Q2 | $384M | Buy |
|
|||||
|
2015
Q1 | $240M | Buy |
|
|||||
|
2014
Q4 | $4.24M | Buy |
|
|||||
|
2014
Q3 | $3.21M | Hold |
|
|||||
|
2014
Q2 | $3.47M | Hold |
|
|||||
|
2014
Q1 | $3.67M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $2M | Buy |
|